{"database": "lobbying", "table": "lobbying_activities", "rows": [[2504238, "9b7e35d9-bc2c-4656-90bf-3ec86f407a91", "Q3", "RUBICON ADVISORS, LLC", 315091, "AVET PHARMACEUTICALS", 2020, "third_quarter", "PHA", "GENERIC DRUG PRICING,HOUSE COMMITTEE ON OVERSIGHT,GOVERNMENT REFORM, FOOD AND DRUG ADMINISTRATION AND COVID-19 DRUG SHORTAGES", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES", 30000, null, 0, 0, "2020-10-06T11:18:02.390000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2504238"], "units": {}, "query_ms": 5.296210991218686, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}